|Amy M. Winslow|
Amy M. Winslow has over 23 years of experience in diagnostics and medical devices, and joined the Company as part of Meridian’s acquisition of Magellan Diagnostics in March 2016. Before joining Magellan in 2011, Amy had a strategy and marketing consulting practice and prior to that served as Vice President, Marketing for Athena Diagnostics (acquired by Quest Diagnostics), a specialty reference laboratory focused on novel diagnostic testing services in neurology, nephrology and endocrinology. Amy began her career as a product manager at C.R. Bard and also served as a Marketing Manager for Genzyme Transgenics.